TL-925

· Telios Pharma, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TL-925, covering 2023-11-18 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis [Phase 2]